Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant

Role of GABAAreceptors in the physiology and pharmacology of sleep

(2009) Raphaëlle Winsky-Sommerer   EUROPEAN JOURNAL OF NEUROSCIENCE

Sleep function: current questions and new approaches

(2009) Anne Vassalli et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Biomedical Application of Orexin/Hypocretin Receptor Ligands in Neuroscience

(2009) Christoph Boss et al.   JOURNAL OF MEDICINAL CHEMISTRY

Sleep benefits subsequent hippocampal functioning

(2009) Ysbrand D Van Der Werf et al.   NATURE NEUROSCIENCE

Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System

(2009) N. Tsujino et al.   PHARMACOLOGICAL REVIEWS

The whats and whens of sleep-dependent memory consolidation

(2009) Susanne Diekelmann et al.   SLEEP MEDICINE REVIEWS

Zolpidem-induced amnesia and somnambulism: Rare occurrences?

(2008) Jui-Hsiu Tsai et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A 2,3 selective agonist, in comparison with lorazepam in healthy volunteers

(2008) SL de Haas et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time

(2008) Keith A. Wafford et al.   NATURE REVIEWS DRUG DISCOVERY

Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a reference

(2008) Gary Zammit et al.   BMC Geriatrics